The American Journal of Medicine
Volume 120, Issue 9, Supplement 1 , Pages S25-S31, September 2007

What Is the Potential Role of Cannabinoid-1 Receptor Blockade in Glucose and Lipid Management?

  • Michael D. Jensen, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Michael D. Jensen, MD, Endocrine Research Unit, Division of Endocrinology, Diabetes, Metabolism, & Nutrition, 5-194 Joseph, Mayo Clinic, Rochester, Minnesota 55905.

Endocrine Research Unit, Division of Endocrinology, Diabetes, Metabolism, & Nutrition, Mayo College of Medicine and Obesity Treatment Clinic, Rochester, Minnesota, USA.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0002-9343(07)00549-9

doi:10.1016/j.amjmed.2007.06.011

The American Journal of Medicine
Volume 120, Issue 9, Supplement 1 , Pages S25-S31, September 2007

Article Tools

* Image Usage & Resolution